Call for Abstract
Scientific Program
International Conference on Parkinson’s Disease & Movement Disorders, will be organized around the theme “Leading innovations and remedial insights into the parkinsons disease”
Parkinsons-2015 is comprised of 10 tracks and 65 sessions designed to offer comprehensive sessions that address current issues in Parkinsons-2015.
Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.
Register now for the conference by choosing an appropriate package suitable to you.
- Track 1-1Age of onset
- Track 1-2Brain physiology and circuitry
- Track 1-3Role of synaptic dysfunction
- Track 1-4Protein Misfolding & Aggregation
- Track 2-1Non Pharmacological Treatment
- Track 2-2Dyskinesia associated with old and new therapies
- Track 2-3Surgical therapy, including gene therapy
- Track 2-4Improving clinical translation of cell therapy
- Track 2-5Treatment of dystonia and tremor
- Track 2-6Deep brain stimulation
- Track 2-7Continuous dopaminergic stimulation (CDS)-based therapies
- Track 2-8Neural transplantation and Neuroprotective treatments
- Track 2-9Dopamine replacement therapy for Parkinsons disease
- Track 2-10Stem cells therapy
- Track 3-1Huntington Disease
- Track 3-2Ataxia and Tardive Dyskinesia
- Track 3-3Restless Legs Syndrome
- Track 3-4Wilson Disease
- Track 3-5Dystonia and Tremors
- Track 3-6Myoclonus and Chorea
- Track 3-7Tics/Tourette’s Syndrome
- Track 4-1Anxiety & Depression
- Track 4-2Gait and balance
- Track 4-3Diet and Nutrition in Parkinsons disease
- Track 4-4Muscle weakness & Fatigue
- Track 4-5Bradykinesia and akinesia
- Track 4-6Postural reflex impairment
- Track 4-7Exercise and lifestyle
- Track 4-8Stress in parkinsons
- Track 5-1Pathology of movement disorders in adolescents
- Track 5-2Gait disturbance in Parkinson’s disease
- Track 5-3Postural control or locomotors defect
- Track 5-4Clinical, neuroanatomical and genetic perspectives
- Track 5-5Pathology, progression and heterogeneity of Parkinson’s disease
- Track 6-1Multiple system atrophy
- Track 6-2Impact of vascular factors
- Track 6-3Genetics in Vasculogenesis
- Track 6-4Angioblasts
- Track 6-5Endothelial precursor in cell migration
- Track 7-1Behavioral and Neuropsychiatric Impulse control disorders
- Track 7-2Pediatric movement disorders
- Track 7-3Autoimmune movement disorders
- Track 7-4Parkinsons related dementia and Amnesia
- Track 7-5Amyotrophic Lateral Sclerosis (ALS)
- Track 7-6Drug-Induced movement disorders
- Track 7-7Sleep Issues in Parkinson Disease
- Track 7-8Delirium and aphasia
- Track 7-9Aging and Neurodegenerative Spasticity
- Track 8-1A practical approach to diagnosis, measurement and management
- Track 8-2Biomarkers for early diagnosis
- Track 8-3CT Scan, PET/PCT Scan
- Track 8-4MRI
- Track 8-5Motor/non motor Symptoms of PD
- Track 8-6Muscle cramps
- Track 9-1Internal medicine in Movement disorders
- Track 9-2Animal and cellular models of Parkinsons
- Track 9-3Cell implantation and Clinical electrophysiology
- Track 9-4Contribution of nuclear medicine to Parkinson
- Track 9-5Methods to improve the recognition of mood disorders
- Track 9-6Therapies in development
- Track 10-1Genetical mutation
- Track 10-2Exposure to neurotoxins
- Track 10-3Environmental triggers
- Track 10-4The presence of lewy bodies
- Track 10-5Imbalance in neurotransmitters